Clinical trials
REM Sleep Behavior Disorder trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Chinese University of Hong Kong | 7 |
| University Hospital, Clermont-Ferrand | 4 |
| Seoul National University Hospital | 2 |
| Czech Technical University in Prague | 1 |
| Hospital de Clinicas de Porto Alegre | 1 |
| Oasi Research Institute-IRCCS | 1 |
| Oregon Health and Science University | 1 |
| Tang-Du Hospital | 1 |
| The Parkinson's Institute | 1 |
| The University of Texas Health Science Center, Houston | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| REM Sleep Behavior Disorder | 21 |
| Parkinson Disease | 10 |
| Narcolepsy | 2 |
| Nerve Degeneration | 2 |
| Parkinsonian Disorders | 2 |
| Cataplexy | 1 |
| Dysarthria | 1 |
| Neurodegenerative Diseases | 1 |
| Prodromal Symptoms | 1 |
| Sleep Wake Disorders | 1 |
Trials
Showing 51 to 21 of 21. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.